Eli Lilly & Co. vs. Praxis Precision Medicines, Inc. Common Stock
LLY
Eli Lilly & Co.
$1184.83 +0.12%
VS PRAXPraxis Precision Medicines, Inc. Common Stock
$334.58 -1.18%
Eli Lilly & Co. (LLY) comes out ahead, leading on 5 of 6 compared factors.
Size & Scale
| LLY | PRAX | |
|---|---|---|
| Market Cap | $1.05 trillion | $9.34 billion |
| Revenue (TTM) | $79.67 billion | — |
| Net Income (TTM) | $26.71 billion | $-339,126,000 |
LLY leads on 3 of 3 size & scale factors.
Valuation
| LLY | PRAX | |
|---|---|---|
| P/E Ratio | 39.77 | — |
| Price / Book | 31.14 | 6.97 |
| Price / Sales | 13.24 | — |
PRAX leads on 1 of 1 valuation factors.
Profitability
| LLY | PRAX | |
|---|---|---|
| Net Margin | 33.53% | — |
| Return on Equity | 78.84% | -25.29% |
LLY leads on 1 of 1 profitability factors.
Dividend
| LLY | PRAX | |
|---|---|---|
| Dividend Yield | 0.58% | — |
| Payout Ratio | 23.23 | — |
LLY and PRAX split the dividend factors evenly.
Risk & Sentiment
| LLY | PRAX | |
|---|---|---|
| Short Interest | 1.29% | 1.95% |
LLY leads on 1 of 1 risk & sentiment factors.
Dig deeper: LLY overview, LLY financials, PRAX overview, PRAX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.